Deep learning for molecular generation.

Area of Science:

• Computational chemistry
• Medicinal chemistry
• Artificial intelligence in drug discovery

Background:

• De novo drug design focuses on creating novel chemical compounds with desired properties computationally.
• Deep generative neural networks represent a significant advancement in automated molecular generation and optimization.

Purpose of the Study:

• To review recent developments in deep learning models for molecular generation in de novo drug design.
• To summarize various generative architectures and optimization strategies.
• To discuss future research directions in this field.

Main Methods:

• Review of recent literature on deep learning models for de novo drug design.
• Categorization of models into four distinct generative architectures.
• Summary of four different optimization strategies employed.

Main Results:

• Deep generative models offer a promising new avenue for drug discovery.
• The review categorizes current deep learning approaches for molecular generation.
• Key optimization strategies are identified and discussed.

Conclusions:

• Deep learning models are transforming de novo drug design.
• Understanding different architectures and optimization methods is crucial for advancing the field.
• Future research should focus on further developing deep generative models for drug discovery.